Status:
RECRUITING
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Carcinoma
Eligibility:
MALE
18+ years
Brief Summary
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collectin...
Detailed Description
PRIMARY OBJECTIVE: I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer. OUTLINE: This is an observational study. Pati...
Eligibility Criteria
Inclusion
- Men of all racial and ethnic groups 18 years of age or older
- Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
- Prior participation on clinical trials is allowed
Exclusion
- Inability to give informed consent
- Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Key Trial Info
Start Date :
February 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 21 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06067295
Start Date
February 21 2023
End Date
February 21 2027
Last Update
August 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles General Medical Center
Los Angeles, California, United States, 90033
2
USC / Norris Comprehensive Cancer Center
Los Angeles, California, United States, 90033